Vimentin was found to be detectable in astrocytomas and glioblastomas (grade IV astrocytomas), meningiomas, and ependymomas but not in oligodendrogliomas and medulloblastomas [15], [16]. This evidence concerns the gene VIM and astrocytoma (excluding glioblastoma).